IT Tech Packaging, Inc. Announces NYSE Regulation Acceptance of Extension Request; Listing Continued Pursuant to Extension Through April 15, 2027
Company granted plan period through April 15, 2027 to complete delayed SEC periodic filings BAODING, China, Oct. 9, 2026 /PRNewswire/ -- IT Tech Packaging, Inc. (NYSE American: ITP) ("ITP" or the "Company"), a leading manufacturer and distributor of...
China Automotive Systems' Fully Redundant AP04 EPS Platform Receives UL ISO 26262 ASIL-D Functional Safety Product Certification
WUHAN, China, Oct. 9, 2026 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that its wholly owned subsidiary, Hubei Henglong...
Health In Tech Launches HitRix, a Broker-First Environment for Self-Funded Stop-Loss Placement
Broker-first marketplace brings submission intake, market routing, quote comparison and case tracking into one coordinated process. STUART, Fla., Oct. 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT) ("Health In Tech" or the "Company"), an...
China Automotive Systems' Fully Redundant AP04 EPS Platform Meets ASPICE 4.0 CL2 in Joint Assessment by European OEM and UL
WUHAN, China, Oct. 5, 2026 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that its wholly owned subsidiary, Hubei Henglong...
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.
OMLYCLO ® (omalizumab-igec) is the first and only FDA-approved omalizumab biosimilar approved for all four indications of XOLAIR ® (omalizumab) and designated as interchangeable with XOLAIR; OMLYCLO ® will be available in 75 mg/0.5 mL, 150 mg/mL and...
Celaid Therapeutics Completes Second Close of Series B Financing Round
Shionogi & Co., Ltd. and Teikoku Ventures, Inc. Join the Round to Accelerate U.S. Clinical Trial Preparations for CLD-001 TOKYO, Oct. 5, 2026 /PRNewswire/ -- Celaid Therapeutics Inc. (Head Office: Bunkyo-ku, Tokyo, Japan; President and CEO:...
Toshiba Information Equipment (Philippines) Celebrates 30th Anniversary and First Shipment from Expanded Nearline HDD Production Line
Expanding production capacity to support growing AI- and cloud-driven demand for high-capacity data center storage LAGUNA, Philippines, Oct. 2, 2026 /PRNewswire/ -- Toshiba Information Equipment (Philippines), Inc. ("TIP"), a hard disk drive...
Health In Tech to Attend the 17th Annual Craig-Hallum Alpha Select Conference
STUART, Fla., Oct. 2, 2026 /PRNewswire/ -- Health In Tech, Inc. (Nasdaq: HIT), an AI-enabled InsurTech platform company ("Health In Tech" or the "Company"), today announced that representatives from the Company's management and investor relations...
Health In Tech Launches HitRix to Modernize the Nearly $1 Trillion U.S. Self-Funded Health Insurance Market and Announces Updated 2026 Full-Year Revenue Guidance
AI-powered HitRix platform streamlines large-group submissions, multi-market quoting, proposal comparison and placement in one secure environment, thereby reducing time to market. STUART, Fla., Oct. 1, 2026 /PRNewswire/ -- Health In Tech, Inc....
ReTo Eco-Solutions, Inc. Announces Share Consolidation
BEIJING, Sept. 29, 2026 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company") today announced that its board of directors approved a combination of its Class A shares, no par value (the "Class A Shares"), on a...